Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

AVEIR DR Coverage With Evidence Development (CED) Study

NCT: NCT05932602 · ACTIVE_NOT_RECRUITING

NCT IDNCT05932602
StatusACTIVE_NOT_RECRUITING
Start Date2023-10-31
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the dual chamber Aveir Leadless Pacemaker device (aka Aveir™ DR LP system).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑